MLchartDataset catalogue

Rezlidhia

Term · Oncology and biomedicine · MLC-T-ONC-007422

A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Rezlidhia blocks the protein made by the mutated IDH1 gene. Blocking this protein may help keep cancer cells from growing. Rezlidhia is a type of enzyme inhibitor. Also called olutasidenib.

Table 1. Record
IdentifierMLC-T-ONC-007422
FieldOncology and biomedicine
Synonymsolutasidenib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007422",
  "term": "Rezlidhia",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Rezlidhia blocks the protein made by the mutated IDH1 gene. Blocking this protein may help keep cancer cells from growing. Rezlidhia is a type of enzyme inhibitor. Also called olutasidenib.",
  "synonyms": [
    "olutasidenib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rezlidhia/"
}

Record 14,435 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.